疼痛管理デバイス市場

出版：MarketsandMarkets（マーケッツアンドマーケッツ）　出版年月：2021年11月

疼痛管理デバイス市場:タイプ（神経刺激、SCS、TENS、RFアブレーション、輸液ポンプ）、用途（神経障害、がん、顔面、MSK、片頭痛）、購入方法（OTC、処方ベース）、地域（北米、ヨーロッパ、APAC）- 2026年までの世界予測

Pain Management Devices Market by Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Neuropathy, Cancer, Facial, MSK, Migraine), Mode of Purchase (OTC, Prescription-based) & Region (NA, Europe, APAC) – Global Forecasts to 2026

–

–

The global pain management devices market is projected to reach USD 3.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 8.6% during the forecast period Pain management devices are used to manage chronic and acute pain in patients suffering from various types of disease conditions, such as cancer, neurological disorders, and musculoskeletal disorders, among others. These devices restore the ability to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions. However, product recalls and high procedural costs likely to challenge market growth in the coming years.

Neurostimulation devices to hold the largest segment of the market
Based on type, the pain management devices market is segmented into neurostimulation devices, infusion pumps, and ablation devices. In 2020, the neurostimulation segment accounted for 58.0% of the pain management devices market. Neurostimulation devices provide pain relief by disrupting pain signals traveling between the spinal cord and the brain. These devices can be either implantable or non-implantable in nature. Neuromodulation devices are further classified into transcutaneous electrical nerve stimulators (TENS) and spinal cord stimulators. The large share and high growth of this segment is attributed to advantages of neuromodulation as compared to alternative therapies for managing chronic pain, its long-term cost effectivity and technological developments in the neurostimulation devices segment.

Neuropathic pain to hold the largest share of the applications market
Based on application, the pain management devices market is segmented into neuropathic pain, musculoskeletal pain, cancer pain, facial pain & migraine, and other applications. The neuropathic pain segment accounted for the largest market share of 31.4% in 2020. The presence of substantial clinical evidences in the favor of high efficacy of pain management devices in neuropathic pain treatment, development of novel neuropathic pain management devices, rising aging population across the globe (geriatric population is at high risk of neuropathic pain due to the increased incidence of neuropathic pain associated with many age-related diseases), side effects of drugs used to treat neuropathic pain, and availability of reimbursement are fueling the adoption of pain management devices for neuropathic pain treatment are the major factors contributing to the growth of the pain management devices market for neuropathic pain applications.

The US to dominate the pain management devices market in North America
North America dominated the pain management devices market, with a share of 52.3% in 2020, followed by Europe and the Asia Pacific, Latin America, and Middle East & Africa. North America has been among the frontrunners in developing pain management devices services in the healthcare industry. The pain management devices market in the US is expected to offer growth opportunities in the coming years owing to the increasing adoption of pain management devices in ambulatory care centers. Many major global players are also based in the US, owing to which the country has become a center of innovation in the pain management devices market.

Breakdown of supply-side primary interviews: • By Company Type: Tier 1 – 60%, Tier 2 – 30%, and Tier 3 – 10% • By Designation: Director-level – 30%, C-level – 50%, and Others – 20% • By Region: North America – 45%, Europe – 15%, APAC –25%, Rest of the World –15%
Some of the prominent players operating in the pain management devices market are Medtronic PLC (Ireland), Boston Scientific (US), Abbott (US), Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), Stryker (US), Smiths Medical (US), Moog Inc. (US), Avanos Medical, Inc. (US), Nipro Corporation (Japan), Atricure (US), Nevro Corp. (US), Micrel Medical Devices SA (Greece), InfuTronix Solutions LLC (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Shenzhen MedRena Biotech Co., Ltd. (China), Epic Medical (Singapore), Bioness (US), Microtransponder (US), Neuronano (Sweden), Gimer Medical (Taiwan), Bluewind Medical (Israel), Soterix Medical Inc. (US) and other players.

Research Coverage
This report studies the pain management devices market based on type, mode of purchase, and application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to two main geographies – source and destination.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

目次

1INTRODUCTION30
1.1OBJECTIVES OF THE STUDY30
1.2MARKET DEFINITION30
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY31
1.3MARKET SCOPE31
1.3.1MARKETS COVERED31
1.3.2YEARS CONSIDERED FOR THE STUDY32
1.3.3CURRENCY32
1.4STAKEHOLDERS33
1.5SUMMARY OF CHANGES33
2RESEARCH METHODOLOGY35
2.1RESEARCH APPROACH35
2.2RESEARCH METHODOLOGY DESIGN35
FIGURE 1PAIN MANAGEMENT DEVICES MARKET: RESEARCH DESIGN35
2.2.1SECONDARY RESEARCH36
2.2.1.1Key data from secondary sources37
2.2.2PRIMARY DATA38
FIGURE 2PRIMARY SOURCES38
2.2.2.1Key data from primary sources39
2.2.2.2Key industry insights39
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION40
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS40
2.3MARKET SIZE ESTIMATION41
FIGURE 5SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS41
FIGURE 6REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC42
FIGURE 7REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: PAIN MANAGEMENT DEVICES MARKET (2020)43
FIGURE 8CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PAIN MANAGEMENT DEVICES MARKET (2021–2026)45
FIGURE 9CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS45
FIGURE 10TOP-DOWN APPROACH46
2.4MARKET BREAKDOWN & DATA TRIANGULATION47
FIGURE 11MARKET DATA TRIANGULATION METHODOLOGY47
2.5MARKET SHARE ANALYSIS48
2.6ASSUMPTIONS FOR THE STUDY48
2.7RISK ASSESSMENT49
TABLE 1RISK ASSESSMENT: PAIN MANAGEMENT DEVICES MARKET49
2.8LIMITATIONS49
2.8.1METHODOLOGY-RELATED LIMITATIONS49
2.8.2SCOPE-RELATED LIMITATIONS49
3EXECUTIVE SUMMARY50
FIGURE 12PAIN MANAGEMENT DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION)50
FIGURE 13NEUROSTIMULATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)51
FIGURE 14INFUSION PUMP MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)51
FIGURE 15ABLATION DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)52
FIGURE 16PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION)52
FIGURE 17PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE,
2021 VS. 2026 (USD MILLION)53
FIGURE 18GEOGRAPHIC SNAPSHOT: INFUSION PUMPS MARKET54
4PREMIUM INSIGHTS56
4.1PAIN MANAGEMENT DEVICES MARKET OVERVIEW56
FIGURE 19GROWING DEMAND FOR LONG-TERM PAIN MANAGEMENT AMONG THE GERIATRIC POPULATION—PRIMARY MARKET DRIVER56
4.2ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET SHARE, BY APPLICATION & REGION (2020)57
FIGURE 20NEUROSTIMULATION TO HOLD THE LARGEST SHARE OF THE ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET IN 202057
4.3PAIN MANAGEMENT DEVICES MARKET: GEOGRAPHIC MIX58
FIGURE 21THE US TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD58
4.4REGIONAL MIX: PAIN MANAGEMENT DEVICES MARKET59
FIGURE 22NORTH AMERICA DOMINATED THE MARKET IN 202059
5MARKET OVERVIEW60
5.1INTRODUCTION60
5.2MARKET DYNAMICS60
FIGURE 23PAIN MANAGEMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES60
5.2.1MARKET DRIVERS61
5.2.1.1Rising demand for chronic pain management in home care settings61
5.2.1.2Growing number of surgical procedures performed61
5.2.1.3Rising prevalence of neurological disorders62
5.2.1.3.1Growing incidence of sports injuries and cancer62
TABLE 2COUNTRY-WISE CANCER INCIDENCE PER MILLION POPULATION, 2015–201963
5.2.1.4Established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries63
5.2.2MARKET RESTRAINTS64
5.2.2.1Product recalls64
5.2.2.2High procedural and purchase cost of pain management devices64
5.2.3MARKET OPPORTUNITIES65
5.2.3.1High growth opportunities in emerging countries65
TABLE 3RISING INCOME LEVELS IN EMERGING COUNTRIES65
5.2.3.2Expanding base of pain management clinics/centers across the globe66
5.2.3.3Use of pain medications as the first line of treatment for pain management66
5.2.3.4Stringent regulatory guidelines delay the adoption of novel devices67
TABLE 4PRESENCE OF ALTERNATIVE THERAPIES FOR PAIN MANAGEMENT IS A MAJOR MARKET CHALLENGE67
5.3REGULATORY LANDSCAPE68
TABLE 5INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING PAIN MANAGEMENT DEVICES68
5.3.1NORTH AMERICA69
5.3.1.1US69
TABLE 6US FDA: MEDICAL DEVICE CLASSIFICATION69
TABLE 7US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS69
FIGURE 24PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES70
5.3.1.2Canada70
FIGURE 25CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES71
5.3.2EUROPE72
FIGURE 26EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES73
5.3.3ASIA PACIFIC74
5.3.3.1Japan74
TABLE 9JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)74
5.3.3.2China74
TABLE 10CHINA: CLASSIFICATION OF MEDICAL DEVICES75
5.3.3.3India76
FIGURE 27LATIN AMERICA: REGULATORY SCENARIO77
5.3.3.4Brazil77
FIGURE 28BRAZIL: REGULATORY PROCESS FOR MEDICAL DEVICES78
TABLE 11BRAZIL: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS78
5.3.3.5Mexico79
FIGURE 29MEXICO: REGULATORY PROCESS FOR MEDICAL DEVICES79
TABLE 12MEXICO: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS80
5.4VALUE CHAIN ANALYSIS80
FIGURE 30PAIN MANAGEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS81
5.5SUPPLY CHAIN ANALYSIS81
FIGURE 31PAIN MANAGEMENT DEVICES MARKET: SUPPLY CHAIN ANALYSIS82
5.6PORTER’S FIVE FORCES ANALYSIS83
TABLE 13PORTER’S FIVE FORCES ANALYSIS83
5.6.1THREAT FROM NEW ENTRANTS84
5.6.2THREAT FROM SUBSTITUTES84
5.6.3BARGAINING POWER OF SUPPLIERS84
5.6.4BARGAINING POWER OF BUYERS85
5.6.5COMPETITIVE RIVALRY85
5.7INDUSTRY TRENDS85
5.7.1WEARABLE DEVICES85
5.7.2RISING POPULARITY OF RECHARGEABLE SPINAL CORD STIMULATORS85
5.8TRADE ANALYSIS86
5.8.1TRADE ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES86
TABLE 14IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY,
2016–2020 (USD BILLION)86
5.9COVID-19 IMPACT ON THE PAIN MANAGEMENT DEVICES MARKET86
6PAIN MANAGEMENT DEVICES MARKET, BY TYPE88
6.1INTRODUCTION89
TABLE 15PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)89
6.2NEUROSTIMULATION DEVICES89
TABLE 16NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)90
TABLE 17NEUROSTIMULATION DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION)90
6.2.1TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICES90
6.2.1.1Extensive use in healthcare, low cost, and ease of use will favor market growth90
TABLE 18TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)91
6.2.2SPINAL CORD STIMULATION91
6.2.2.1Rising incidence of indications and efficacy & reversibility of procedure have supported the adoption of SCS91
TABLE 19SPINAL CORD STIMULATION DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)92
6.3INFUSION PUMPS92
6.3.1HIGH USE OF INFUSION PUMPS IN POSTOPERATIVE PAIN MANAGEMENT92
TABLE 20INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)93
TABLE 21INFUSION PUMPS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)93
6.3.2INTRATHECAL INFUSION PUMPS93
TABLE 22INTRATHECAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)94
6.3.3EXTERNAL INFUSION PUMPS94
TABLE 23EXTERNAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)95
6.4ABLATION DEVICES95
TABLE 24ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)95
TABLE 25ABLATION DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)96
6.4.1RF ABLATION DEVICES96
TABLE 26RF ABLATION DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)97
6.4.2CRYOABLATION DEVICES97
TABLE 27CRYOABLATION DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)98
7PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION99
7.1INTRODUCTION100
TABLE 28PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)100
7.2NEUROPATHIC PAIN100
7.2.1HIGH PREVALENCE OF DISEASES ASSOCIATED WITH NEUROPATHIC PAIN100
TABLE 29NEUROPATHIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)101
7.3CANCER PAIN101
TABLE 30CANCER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)102
7.4FACIAL PAIN & MIGRAINE102
TABLE 31FACIAL PAIN & MIGRAINE MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)104
7.5MUSCULOSKELETAL PAIN104
TABLE 32MUSCULOSKELETAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)105
7.6OTHER APPLICATIONS105
TABLE 33OTHER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)106
8PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE107
8.1INTRODUCTION108
TABLE 34PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE,
2019–2026 (USD MILLION)108
8.2OVER-THE-COUNTER PAIN MANAGEMENT DEVICES108
8.2.1OTC PAIN MANAGEMENT DEVICES UNFOLD NEW GROWTH AVENUES108
TABLE 35OVER-THE-COUNTER PAIN MANAGEMENT DEVICES MARKET SIZE,
BY REGION, 2019–2026 (USD MILLION)109
8.3PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES109
TABLE 36PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES MARKET SIZE,
BY REGION, 2019–2026 (USD MILLION)110
 
9PAIN MANAGEMENT DEVICES MARKET, BY REGION111
9.1INTRODUCTION112
FIGURE 32PAIN MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES112
TABLE 37GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)113
9.2NORTH AMERICA113
FIGURE 33NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT114
TABLE 38NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)114
TABLE 39NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)115
TABLE 40NORTH AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)115
TABLE 41NORTH AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)115
TABLE 42NORTH AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)116
TABLE 43NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY APPLICATION, 2019–2026 (USD MILLION)116
TABLE 44NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION)116
9.2.1THE US117
9.2.1.1The US is expected to hold the leading position in the market due to the rising geriatric population, increasing prevalence of chronic diseases, and the growing home healthcare market117
TABLE 45KEY MACROINDICATORS FOR THE US117
TABLE 46US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)118
TABLE 47US: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)118
TABLE 48US: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)118
TABLE 49US: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)119
TABLE 50US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)119
TABLE 51US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)119
9.2.2CANADA120
9.2.2.1Increasing incidence of chronic pain indications to support the adoption of pain management devices in Canada120
TABLE 52KEY MACROINDICATORS FOR CANADA120
TABLE 53CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)121
TABLE 54CANADA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)121
TABLE 55CANADA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)121
TABLE 56CANADA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)122
TABLE 57CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)122
TABLE 58CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION)122
9.3EUROPE123
TABLE 59EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY,
2019–2026 (USD MILLION)124
TABLE 60EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)124
TABLE 61EUROPE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)125
TABLE 62EUROPE: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)125
TABLE 63EUROPE: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)125
TABLE 64EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)126
TABLE 65EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION)126
9.3.1GERMANY126
9.3.1.1Presence of leading pain management device manufacturers to drive market growth in Germany126
TABLE 66KEY MACROINDICATORS FOR GERMANY127
TABLE 67GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)128
TABLE 68GERMANY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)128
TABLE 69GERMANY: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)128
TABLE 70GERMANY: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)129
TABLE 71GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)129
TABLE 72GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)129
9.3.2FRANCE130
TABLE 73KEY MACROINDICATORS FOR FRANCE130
TABLE 74FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)131
TABLE 75FRANCE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)131
TABLE 76FRANCE: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)131
TABLE 77FRANCE: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)132
TABLE 78FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)132
TABLE 79FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)132
9.3.3THE UK133
9.3.3.1High burden of chronic pain in the country to propel the
growth of the pain management devices market133
TABLE 80KEY MACROINDICATORS FOR THE UK134
TABLE 81UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)134
TABLE 82UK: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)134
TABLE 83UK: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)135
TABLE 84UK: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)135
TABLE 85UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)135
TABLE 86UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)136
9.3.4ITALY136
9.3.4.1Growing demand for cost-effective home care services to support market growth136
TABLE 87KEY MACROINDICATORS FOR ITALY136
TABLE 88ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)137
TABLE 89ITALY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)137
TABLE 90ITALY: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)138
TABLE 91ITALY: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)138
TABLE 92ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)138
TABLE 93ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)139
9.3.5SPAIN139
9.3.5.1Rising prevalence of cancer to support the market for pain management devices market in Spain139
TABLE 94KEY MACROINDICATORS FOR SPAIN140
TABLE 95SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)140
TABLE 96SPAIN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)140
TABLE 97SPAIN: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)141
TABLE 98SPAIN: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)141
TABLE 99SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)141
TABLE 100SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)142
9.3.6REST OF EUROPE142
TABLE 101ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)143
TABLE 102ROE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)143
TABLE 103ROE: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)143
TABLE 104ROE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)144
TABLE 105ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)144
TABLE 106ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)144
9.4ASIA PACIFIC145
FIGURE 34ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT146
TABLE 107ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)147
TABLE 108ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)147
TABLE 109ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)147
TABLE 110ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)148
TABLE 111ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)148
TABLE 112ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)148
TABLE 113ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION)149
9.4.1JAPAN149
9.4.1.1Large geriatric population in the country is driving the demand for infusion pumps149
TABLE 114KEY MACRO INDICATORS FOR JAPAN150
TABLE 115JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)150
TABLE 116JAPAN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)150
TABLE 117JAPAN: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)151
TABLE 118JAPAN: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)151
TABLE 119JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)151
TABLE 120JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)152
9.4.2CHINA152
9.4.2.1Growing investments in healthcare infrastructure development in the country to drive market growth in China152
TABLE 121KEY MACRO INDICATORS FOR CHINA153
TABLE 122CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)153
TABLE 123CHINA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)153
TABLE 124CHINA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)154
TABLE 125CHINA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)154
TABLE 126CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)154
TABLE 127CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)155
9.4.3INDIA155
9.4.3.1High prevalence of lifestyle diseases in the country to drive the market for pain management devices market155
TABLE 128KEY MACRO INDICATORS FOR INDIA156
TABLE 129INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)156
TABLE 130INDIA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)156
TABLE 131INDIA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)157
TABLE 132INDIA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)157
TABLE 133INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)157
TABLE 134INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)158
9.4.4REST OF ASIA PACIFIC158
9.4.4.1High prevalence of chronic diseases in the region to drive the market for pain management devices158
FIGURE 35PREVALENCE OF DIABETES IN SOUTHEAST ASIA (2018/2019)159
TABLE 135ESTIMATED NUMBER OF CANCER CASES IN SOUTHEAST ASIAN COUNTRIES, 2020 VS. 2040 (IN THOUSAND)159
FIGURE 36HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2018)159
FIGURE 37GERIATRIC POPULATION IN 2019 (% OF TOTAL POPULATION)160
TABLE 136REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)160
TABLE 137REST OF ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE,
BY TYPE, 2019–2026 (USD MILLION)160
TABLE 138REST OF ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)161
TABLE 139REST OF ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)161
TABLE 140REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY APPLICATION, 2019–2026 (USD MILLION)161
TABLE 141REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION)162
9.5LATIN AMERICA162
TABLE 142LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)163
TABLE 143LATIN AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)163
TABLE 144LATIN AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)163
TABLE 145LATIN AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)164
TABLE 146LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY APPLICATION, 2019–2026 (USD MILLION)164
TABLE 147LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION)164
9.6MIDDLE EAST AND AFRICA165
9.6.1IMPROVING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH165
TABLE 148MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY TYPE, 2019–2026 (USD MILLION)165
TABLE 149MIDDLE EAST & AFRICA: NEUROSTIMULATION DEVICES MARKET SIZE,
BY TYPE, 2019–2026 (USD MILLION)166
TABLE 150MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)166
TABLE 151MIDDLE EAST & AFRICA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)166
TABLE 152MIDDLE EAST AND AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY APPLICATION, 2019–2026 (USD MILLION)167
TABLE 153MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION)167
10COMPETITIVE LANDSCAPE168
10.1OVERVIEW168
FIGURE 38KEY DEVELOPMENTS OF PROMINENT PLAYERS OPERATING IN PAIN MANAGEMENT DEVICES MARKET (2020-2021)169
10.2REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS170
FIGURE 39REVENUE ANALYSIS OF THE TOP PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET170
10.3MARKET SHARE ANALYSIS170
FIGURE 40PAIN MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2020171
10.4COMPANY EVALUATION QUADRANT172
10.4.1STARS172
10.4.2EMERGING LEADERS172
10.4.3PERVASIVE PLAYERS172
10.4.4PARTICIPANTS173
FIGURE 41PAIN MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT (2020)173
10.5COMPANY EVALUATION QUADRANT FOR START-UPS174
10.5.1PROGRESSIVE COMPANIES174
10.5.2DYNAMIC COMPANIES174
10.5.3STARTING BLOCKS174
10.5.4RESPONSIVE COMPANIES174
FIGURE 42PAIN MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020)175
10.6COMPANY PRODUCT FOOTPRINT176
TABLE 154PRODUCT PORTFOLIO ANALYSIS: PAIN MANAGEMENT DEVICES MARKET176
10.7GEOGRAPHIC FOOTPRINT OF THE MAJOR PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET177
TABLE 155GEOGRAPHIC REVENUE MIX: PAIN MANAGEMENT DEVICES MARKET (2020)177
10.8COMPETITIVE SCENARIO178
10.8.1PRODUCT LAUNCHES178
TABLE 156PRODUCT LAUNCHES (JANUARY 2018 – JUNE 2021)178
10.8.2DEALS181
TABLE 157DEALS (JANUARY 2018–JUNE 2021)181
10.8.3OTHER DEVELOPMENTS183
TABLE 158OTHER DEVELOPMENTS (JANUARY 2018– JUNE 2021)183
11COMPANY PROFILES184
11.1KEY PLAYERS184
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1MEDTRONIC184
TABLE 159MEDTRONIC PLC: BUSINESS OVERVIEW184
FIGURE 43MEDTRONIC PLC: COMPANY SNAPSHOT (2020)185
11.1.2ABBOTT LABORATORIES188
TABLE 160ABBOTT LABORATORIES: BUSINESS OVERVIEW188
FIGURE 44ABBOTT LABORATORIES: COMPANY SNAPSHOT188
TABLE 161ABBOTT LABORATORIES: PRODUCT OFFERINGS189
11.1.3BOSTON SCIENTIFIC CORPORATION191
TABLE 162BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW191
FIGURE 45BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT192
TABLE 163BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERINGS193
11.1.4STRYKER CORPORATION195
TABLE 164STRYKER: BUSINESS OVERVIEW195
FIGURE 46STRYKER CORPORATION: COMPANY SNAPSHOT196
TABLE 165STRYKER: PRODUCT OFFERINGS196
11.1.5BECTON, DICKINSON AND COMPANY198
TABLE 166BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW198
FIGURE 47BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)199
11.1.6B. BRAUN MELSUNGEN AG202
TABLE 167B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW202
FIGURE 48B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020)203
11.1.7BAXTER INTERNATIONAL INC.207
TABLE 168BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW207
FIGURE 49BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2020)208
11.1.8AVANOS MEDICAL, INC.211
TABLE 169AVANOS MEDICAL, INC.: BUSINESS OVERVIEW211
FIGURE 50AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2020)212
11.1.9TELEFLEX, INC.214
TABLE 170TELEFLEX, INC.: BUSINESS OVERVIEW214
FIGURE 51TELEFLEX, INC.: COMPANY SNAPSHOT (2020)215
11.1.10SMITHS MEDICAL216
TABLE 171SMITHS MEDICAL: BUSINESS OVERVIEW216
FIGURE 52SMITHS MEDICAL: COMPANY SNAPSHOT (2020)217
11.1.11NIPRO CORPORATION219
TABLE 172NIPRO CORPORATION: BUSINESS OVERVIEW219
FIGURE 53NIPRO CORPORATION: COMPANY SNAPSHOT (2019)220
11.1.12MOOG INC.222
TABLE 173MOOG INC.: BUSINESS OVERVIEW222
FIGURE 54MOOG INC.: COMPANY SNAPSHOT (2020)223
11.1.13ATRICURE225
TABLE 174ATRICURE: BUSINESS OVERVIEW225
FIGURE 55ATRICURE: COMPANY SNAPSHOT225
TABLE 175ATRICURE: PRODUCT OFFERINGS226
11.1.14NEVRO CORP.227
TABLE 176NEVRO CORP: BUSINESS OVERVIEW227
FIGURE 56NEVRO CORP.: COMPANY SNAPSHOT227
TABLE 177NEVRO CORP: PRODUCT OFFERINGS228
11.1.15MICREL MEDICAL DEVICES SA229
TABLE 178MICREL MEDICAL DEVICES SA: BUSINESS OVERVIEW229
11.1.16MINDRAY MEDICAL INTERNATIONAL LIMITED231
TABLE 179MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW231
11.1.17SHENZHEN MEDRENA BIOTECH CO., LTD.233
TABLE 180SHENZHEN MEDRENA BIOTECH CO., LTD.: BUSINESS OVERVIEW233
11.1.18EPIC MEDICAL234
TABLE 181EPIC MEDICAL: BUSINESS OVERVIEW234
11.1.19BIONESS235
11.1.20SOTERIX MEDICAL236
11.2OTHER PLAYERS237
11.2.1INFUTRONIX SOLUTIONS LLC237
TABLE 182INFUTRONIX SOLUTIONS LLC: BUSINESS OVERVIEW237
11.2.2GIMER MEDICAL239
11.2.3BLUEWIND MEDICAL239
11.2.4NEURONANO239
11.2.5MICROTRANSPONDER240
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12APPENDIX241
12.1DISCUSSION GUIDE241
12.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL245
12.3AVAILABLE CUSTOMIZATIONS247
12.4RELATED REPORTS248
12.5AUTHOR DETAILS249

お問合せフォーム